Amarin Pharma

FunderResearch funding and supported work

Amarin Pharma is a funder indexed in ScholarIQ from OpenAlex. ScholarIQ records 155 works.

155

Works

IDs:OpenAlex

What are the most-cited papers on Amarin Pharma?

ScholarIQmost cited works

Analysis of Worsening Heart Failure Events in an Integrated Health Care System

Andrew P. Ambrosy, Rishi Parikh, Sue Hee Sung, Thida C. Tan, Anand Narayanan, Rajeev Masson, Phuong-Quang Lam, Kevin Kheder, Alan Iwahashi, Alexander Hardwick, Jesse K. Fitzpatrick, Harshith R. Avula, Van Selby, Ivy A. Ku, Xian Shen, Navneet Sanghera, Joaquim Cristino, Alan S. Go

Journal of the American College of Cardiology. 202261 CitationsOPEN ACCESS

Safety and Efficacy of Intravenous Ferric Derisomaltose Compared to Iron Sucrose for Iron Deficiency Anemia in Patients with Chronic Kidney Disease With and Without Heart Failure

Andrew P. Ambrosy, Stephan von Haehling, Paul R. Kalra, Emma L. Court, Sunil Bhandari, Theresa A. McDonagh, John G.F. Cleland

The American Journal of Cardiology. 202127 CitationsOPEN ACCESS

Sex-Based Differences in the Epidemiology, Clinical Characteristics, and Outcomes Associated with Worsening Heart Failure Events in a Learning Health System

CHLOE J. LEUNG, Ankeet S. Bhatt, Alan S. Go, Rishi Parikh, Elisha Garcia, KATHY C. LE, Deborah Low, Amanda Allen, Jesse K. Fitzpatrick, Sirtaz Adatya, Dana R. Sax, Parag Goyal, Anubodh S. Varshney, Alexander T. Sandhu, Shanshan Gustafson, Andrew P. Ambrosy

Journal of Cardiac Failure. 20242 CitationsOPEN ACCESS